Available in 5/5mg and 10/10mg stable lyophilized vials
How Retatrutide Compares to Other Weight Loss Medications The Triple Agonist Advantage Retatrutide's unprecedented efficacy stems from its unique mechanism as a triple hormone receptor agonist , activating three complementary pathways: GLP-1 (Glucagon-Like Peptide-1): Reduces appetite, slows gastric emptying, improves insulin secretion GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances GLP-1 effects, improves insulin sensitivity, may affect fat metabolism Glucagon: Increases energy expenditure, promotes fat burning, may improve metabolic rate Head-to-Head Comparison Retatrutide's 6.2 percentage point improvement over tirzepatide and 13.7 percentage point improvement over semaglutide represents a substantial therapeutic advance
When clinically appropriate, our Chandler providers may prescribe GLP-1 medications including semaglutide and tirzepatide as part of a physician-supervised weight loss program
Monitoring your diet and exercise closely will assist you and your provider in determining the most Dosage Recommendations for Diabetes Management When youre managing diabetes with semaglutide, your doctor will tailor your dosage specifically to your needs
The coverage gap exacerbates health inequities: obesity disproportionately affects lower-income and minority populations who rely on public insurance